EQUALINE NIGHTTIME COLD AND FLU RELIEF
-
acetaminophen,
dextromethorphan hydrobromide and
doxylamine succinate liquid
Supervalu Inc
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Acetaminophen 325 mg
Dextromethorphan HBr 15 mg
Doxylamine succinate 6.25 mg
temporarily relieves common cold/flu symptoms:
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Sore throat warning: If sore throat is severe, lasts for more than 2 days, occurs with or is followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222) Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
adults & children 12 yrs & over | 30 ml (2 TBSP) every 6 hrs |
children 4 to under 12 yrs | ask a doctor |
children under 4 yrs | do not use |
alcohol, anhydrous citric acid, D&C yellow no. 10, FD&C green no. 3, FD&C yellow no. 6, flavor, high fructose corn syrup, polyethylene glycol, propylene glycol, purified water, saccharin sodium, sodium citrate
compare to Vicks® NyQuil® active ingredients
multi-symptom
nighttime cold & flu relief
pain reliever/fever reducer - acetaminophen
cough suppressant - dextromethorphan HBr
antihistamine - doxylamine succinate
see new warnings and dosing information
relieves cold and flu-like symptoms so you can rest
10% ALCOHOL
original flavor
NightTime Cold & Flu Relief Label Image 1
NightTime Cold & Flu Relief Label Image 2
EQUALINE NIGHTTIME COLD AND FLU RELIEF
acetaminophen, dextromethorphan hbr, doxylamine succinate liquid |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part341 | 10/17/2011 |
Labeler - Supervalu Inc (006961411) |
Revised: 03/2012 Supervalu Inc